×
Monday, September 21, 2026

Regeneron Investors Can't Use FCA Action To Support Suit - Law360

accusing them of misleading investors about the company's revenue prospects for its vision loss drug and inflating reimbursements, with a judge ruling that the suit does not use the U. S. Department of Justice's False Claims Act suit against the company to plead share losses. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.



Read Full Story: https://news.google.com/rss/articles/CBMinAFBVV95cUxQNzhkbVpOOGgxMHdmMkxSOVht...